Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube

The Official Journal Of The International Society For Pharmacoeconomics And Outcomes Research

Articles in Press

Value in Health offers readers the opportunity to access complete articles (Articles in Press) to be published in upcoming issues of Value in Health. Current Articles in Press can be found at: www.valueinhealthjournal.com, by clicking the “Articles in Press" tab.

Articles that appear in Articles in Press can be found in future issues of Value in Health listed below.  All articles in these future issues have been accepted for publication, and currently may be at any stage in the post-acceptance process, which include copy-editing, typesetting, author review, revisions, and pre-electronic production, with articles in earlier issues appearing sooner than articles in later issues. These accepted articles appear in Articles in Press only after completing the post-acceptance process and remain for viewing until approximately one month prior the hard copy release date (Note: The timeframe from when an article is accepted, and appears and remains in Articles in Press are approximate, pending submission to publisher, extent of typesetting, author turn-around times, revisions, etc. Thus, some accepted articles that appear below may not appear in Articles in Press).

Future Issues:

Value in Health 2015 Volume 18 Issue 6

Editorial

TASK FORCE REPORT

Clinical Outcome Assessments:  Conceptual Foundation. Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force
Walton MK, Powers JH, Hobart J, Patrick DL, Marquis P, Vamvakas, S , Isaac MCano SJ, Burke L

ECONOMIC EVALUATION

The iMTA Productivity Cost Questionnaire A standardized instrument for measuring and valuing health related productivity losses Clazien Bouwmans, MSc; Marieke Krol, PhD; Hans Severens, PhD; Marc Koopmanschap, PhD; Werner Brouwer, PhD; Leona Hakkaart- van Roijen, PhD

Asthma and COPD overlap syndrome (ACOS): Doubled costs compared with asthma patients without COPD Maria Gerhardsson de Verdier, MD, PhD; Maria Andersson, PhD; David Kern, MS; Siting Zhou, PhD; Ozgur Tunceli, PhD

COMPARISON COSTS OF ERCP AND MRCP IN PATIENTS WITH SUSPECTED BILIARY OBSTRUCTION BASED ON A RANDOMIZED TRIAL Viviane ADAM, MSc; Mamatha Bhat, MD, MC; Myriam Martel, BSc; Eduardo da Silveira, MD; Jeffrey Barkun, MD, CM; Alan Barkun, MD, CM

Erlotinib, afatinib, or cisplatin-pemetrexed for first-line treatment of advanced EGFR mutationpositive NSCLC in the US: cost-effectiveness and value of information analysis Jie Ting, PhD, MSPH; Tien Ho, PharmD; Pin Xiang, BA; Amanda L Sugay, BA; Maher Abdel-Sattar, PharmD; Leslie Wilson, PhD, MS

Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom Jameel Nazir; Khaled Maman, MSc; Mohamed-Elmoctar Neine, MSc; Benjamin Briquet, MSc; Isaac A Odeyemi, PhD; Zalmai Hakimi, PharmD; Andy Garnham, MSc; Samuel Aballéa,
MSc

Economic evaluation of quitting smoking on weight gains: evidence from the United Kingdom Luca Pieroni; Liliana Minelli; Luca Salmasi

Cost-effectiveness analysis of alternative antiviral strategies for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B Sarah L Bermingham, MSc; Ralph Hughes; Elisabetta Fenu; Laura Sawyer; Elizabeth Boxall; Patrick Kennedy; Geoff Dusheiko; Grant Hill-Cawthorne; Howard Thomas

A cost-effectiveness analysis of minimally invasive versus open surgery techniques for lumbar spinal fusion in Italy and UK Simona Vertuani, Ph.D; Jonas Nilsson, Ph.D; Benny Borgman; Giorgio Buseghin; Catherine M Leonard; Roberto Assietti, M.D.; Nasir A Quraishi, M.D

PATIENT-REPORTED OUTCOMES

Impact of Etanercept Therapy on Disease Activity and Health-related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort Sameer Kotak; Jack Mardekian ; Nathalie Horowicz-Mehler; Ankit Shah; Andrew Burgess; Joseph Kim; Eric Gemmen; Helen Boyd; Andrew Koenig

Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit Hyperactivity Disorder Juliana Setyawan, PharmD, MS; Hongbo Yang, PhD; David Cheng, BS; Xiaopeng Cai, MS; James Signorovitch, PhD; Jipan Xie, PhD; M. Haim Erder, PhD

PREFERENCE-BASED ASSESSMENTS

Monetary valuation of informal care based on carers' and non-carers' preferences
Silvia Garrido García, Ph.D.; Fernando Ignacio Sánchez Martínez, Ph.D.; José María Abellán Perpiñán, Ph.D.; Job van Exel, Ph.D

Using the Analytic Hierarchy Process to derive health state utilities from ordinal preference data Brian P Reddy, MSc; Roisin Adams, MPharm PhD; Cathal Walsh, PhD; Michael Barry,
MB PhD; Paul Kind , MPhil MSc

Deriving a preference-based measure for myelofibrosis from the EORTC QLQ-C30 and the MFSAF Clara Mukuria, Ph. D.; Donna Rowen, Ph. D.; John Brazier, Ph. D. ; Tracey Young, Ph.D.; Beenish Nafees, MSc

Calculating preference weights for the Labor And Delivery Index (LADY-X): a discrete choice experiment on women's birth experiences Fania Ruth Gärtner, Ph.D.; Esther W de Bekker-Grob, PhD; Anne M Stiggelbout, PhD; Marlies E Rijnders; Liv M Freeman; Johanne M Middeldorp; Kitty W Bloemenkamp; Esteriek de Miranda; M.Elske van den Akker-van Marle

COMPARATIVE EFFECTIVENESS RESEARCH / HTA

Unifying research and reimbursement decisions: Case studies demonstrating the sequence of assessment and judgements required Claire McKenna, PhD; Marta Soares; Karl Claxton; Laura Bojke; Susan Griffin; Stephen Palmer; Eldon Spackman

Estimated Life Years Saved in Women with HER2 Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab In the United States Mark Danese, Ph.D; Anthony Masaquel, Ph.D; Eduardo Santos, MS; Melissa Brammer, MPH; Abraham Lee; Deepa Lalla, Ph.D

Development and validation of a score for adjusting healthcare costs in general practice Francesco Lapi, PhD; Elisa Bianchini, MSc, PhD; Iacopo Cricelli; Gianluca Trifirò, MD, PhD; Giampiero Mazzaglia, MD, PhD; Claudio Cricelli, MD

Impact of statin adherence on cardiovascular morbidity and all-cause mortality in the primary prevention of cardiovascular disease - A population-based cohort study in Finland Piia Rannanheimo, MSc; Pekka Tiittanen, MSc; Juha Hartikainen, Prof; Arja HelinSalmivaara,
PhD; Risto Huupponen, Prof; Jussi Vahtera, Prof; Maarit Jaana Korhonen, PhD

HEALTH POLICY ANALYSIS

Rare Disease Terminology & Definitions - A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group Trevor Richter, MSc PhD; Sandra Nestler-Parr, MPhil, PhD; Robert Babela, MSc, PhD; Zeba M Khan, RPh, PhD; Theresa Tesoro , MSN; Elizabeth Molsen, RN; Dyfrig Hughes, MSc, PhD

SYSTEMATIC REVIEWS

What Guidance are Economists Given on How to Present Economic Evaluations to Policymakers? A Systematic Review Shannon M Sullivan, MSc; George A Wells, PhD; Doug Coyle, PhD

Convergence yet continued complexity: a systematic review and critique of health economic models of relapsing-remitting multiple sclerosis in the United Kingdom Felicity Allen, BVSc MPH; Stephen Maxwell Montgomery, MPharm PhD; Maciej Maruszczak, BSc; Jeanette Kusel, MSci PGDip; Nicholas Adlard, MA MSc MBA


Value in Health Main Page

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2015 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.